These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 34268067)

  • 1. Opportunities, barriers, and recommendations in down syndrome research.
    Hendrix JA; Amon A; Abbeduto L; Agiovlasitis S; Alsaied T; Anderson HA; Bain LJ; Baumer N; Bhattacharyya A; Bogunovic D; Botteron KN; Capone G; Chandan P; Chase I; Chicoine B; Cieuta-Walti C; DeRuisseau LR; Durand S; Esbensen A; Fortea J; Giménez S; Granholm AC; Hahn LJ; Head E; Hillerstrom H; Jacola LM; Janicki MP; Jasien JM; Kamer AR; Kent RD; Khor B; Lawrence JB; Lemonnier C; Lewanda AF; Mobley W; Moore PE; Nelson LP; Oreskovic NM; Osorio RS; Patterson D; Rasmussen SA; Reeves RH; Roizen N; Santoro S; Sherman SL; Talib N; Tapia IE; Walsh KM; Warren SF; White AN; Wong GW; Yi JS
    Transl Sci Rare Dis; 2021; 5(3-4):99-129. PubMed ID: 34268067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further understanding the connection between Alzheimer's disease and Down syndrome.
    Snyder HM; Bain LJ; Brickman AM; Carrillo MC; Esbensen AJ; Espinosa JM; Fernandez F; Fortea J; Hartley SL; Head E; Hendrix J; Kishnani PS; Lai F; Lao P; Lemere C; Mobley W; Mufson EJ; Potter H; Zaman SH; Granholm AC; Rosas HD; Strydom A; Whitten MS; Rafii MS
    Alzheimers Dement; 2020 Jul; 16(7):1065-1077. PubMed ID: 32544310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey.
    Hüls A; Costa ACS; Dierssen M; Baksh RA; Bargagna S; Baumer NT; Brandão AC; Carfi A; Carmona-Iragui M; Chicoine BA; Ghosh S; Lakhanpaul M; Manso C; Mayer MA; Ortega MDC; de Asua DR; Rebillat AS; Russell LA; Sgandurra G; Valentini D; Sherman SL; Strydom A;
    EClinicalMedicine; 2021 Mar; 33():100769. PubMed ID: 33644721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international survey on the impact of COVID-19 in individuals with Down syndrome.
    Hüls A; Costa ACS; Dierssen M; Baksh RA; Bargagna S; Baumer NT; Brandão AC; Carfi A; Carmona-Iragui M; Chicoine BA; Ghosh S; Lakhanpaul M; Manso C; Mayer MA; Del Carmen Ortega M; de Asua DR; Rebillat AS; Russell LA; Sgandurra G; Valentini D; Sherman SL; Strydom A
    medRxiv; 2020 Nov; ():. PubMed ID: 33173907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group.
    Baumer NT; Becker ML; Capone GT; Egan K; Fortea J; Handen BL; Head E; Hendrix JE; Litovsky RY; Strydom A; Tapia IE; Rafii MS
    J Neurodev Disord; 2022 Mar; 14(1):22. PubMed ID: 35321660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort.
    Altuna M; Estanga A; Garrido A; Saldias J; Cañada M; Echeverria M; Larrea JÁ; Ayo P; Fiz A; Muñoz M; Santa-Inés J; García-Landarte V; García-Sebastián M
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations.
    Baumer NT; Capone G
    Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32069. PubMed ID: 37870763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down Syndrome Cures: Perspectives of People With Down Syndrome and Their Parents.
    Rogers JM; Weaver AL; Havyer RD
    Am J Intellect Dev Disabil; 2022 May; 127(3):194-212. PubMed ID: 35443053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Institutes of Health INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project: Accelerating research discoveries for people with Down syndrome across the lifespan.
    Bardhan S; Li H; Tarver E; Schramm C; Brown M; Garcia L; Schwartz B; Mazzucco A; Natarajan N; Walsh E; Ryan L; Pearson G; Parisi MA
    Am J Med Genet C Semin Med Genet; 2024 Mar; 196(1):e32081. PubMed ID: 38197535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurring conditions in children with Down syndrome and autism: a retrospective study.
    Spinazzi NA; Santoro JD; Pawlowski K; Anzueto G; Howe YJ; Patel LR; Baumer NT
    J Neurodev Disord; 2023 Mar; 15(1):9. PubMed ID: 36864370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needs and challenges of daily life for people with Down syndrome residing in the city of Rome, Italy.
    Bertoli M; Biasini G; Calignano MT; Celani G; De Grossi G; Digilio MC; Fermariello CC; Loffredo G; Luchino F; Marchese A; Mazotti S; Menghi B; Razzano C; Tiano C; Zambon Hobart A; Zampino G; Zuccalà G
    J Intellect Disabil Res; 2011 Aug; 55(8):801-20. PubMed ID: 21668802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down syndrome.
    Rafii MS; Kleschevnikov AM; Sawa M; Mobley WC
    Handb Clin Neurol; 2019; 167():321-336. PubMed ID: 31753140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Family Impact in Down Syndrome, Autism Spectrum Disorder, and Co-occurring Down Syndrome and Autism Spectrum Disorder.
    Soccorso C; Milliken A; Hojlo M; Pawlowski K; Weas S; Sideridis G; Baumer N
    J Dev Behav Pediatr; 2023 Apr; 44(3):e185-e195. PubMed ID: 36978233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caregiver knowledge of obstructive sleep apnoea in Down syndrome.
    Giménez S; Tapia IE; Fortea J; Levedowski D; Osorio R; Hendrix J; Hillerstrom H
    J Intellect Disabil Res; 2023 Jan; 67(1):77-88. PubMed ID: 36416001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-disordered breathing in Down syndrome.
    Lal C; White DR; Joseph JE; van Bakergem K; LaRosa A
    Chest; 2015 Feb; 147(2):570-579. PubMed ID: 25644910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS).
    Beresford-Webb JA; Mak E; Grigorova M; Daffern SJ; Holland AJ; Zaman SH
    BJPsych Open; 2021 Apr; 7(3):e79. PubMed ID: 33845926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.